|
|
A "Circuits-First" Platform for Personalized Neurostimulation Treatment |
| 5 DP1 MH116506-06 |
ETKIN, AMIT |
NIMH |
2021 |
|
|
Characterization of functional molecular domains of MeCP2 |
| 5 F30 MH122064-02 |
COLLINS, BRIDGET E |
NIMH |
2021 |
|
|
The role of Neurexin in serotonin synaptic function and social behavior |
| 5 F30 MH122146-02 |
CHEUNG, AMY |
NIMH |
2021 |
|
|
Characterizing Neural Adaptation in Autism Spectrum Disorder |
| 5 F32 MH117933-03 |
DMELLO, ANILA |
NIMH |
2021 |
|
|
Subcellular Mapping and Post-Synaptic Impacts of Striatal Dopamine Release During Behavior |
| 5 F32 MH120894-03 |
VU, MAI-ANH |
NIMH |
2021 |
|
|
Impact of Multisensory Function on Symptomatology in Young Children with ASD |
| 5 K01 MH113819-04 |
JAO KEEHN, R JOANNE |
NIMH |
2021 |
|
|
Project 2_Dougherty: Invasive Recording and Neurostimulation Studies of Approach/Avoidance Behaviors in Humans |
| 5 P50 MH119467-02 |
DOUGHERTY, DARIN D |
NIMH |
2021 |
|
|
Role of the Rett Syndrome-causing gene MeCP2 in 3D chromosomal organization and rescue of cellular disease phenotypes |
| 5 R00 MH113813-04 |
LIU, X SHAWN |
NIMH |
2021 |
|
|
Intercellular TWEAK/Fn14 Cytokine Signaling in Sensory-Dependent Circuit Refinement |
| 5 R00 MH120051-04 |
CHEADLE, LUCAS M |
NIMH |
2021 |
|
|
Dysregulation of mTORC2 and cofilin signaling in Fragile X Syndrome |
| 5 R01 MH092877-12 |
ZUKIN, R SUZANNE |
NIMH |
2021 |
